Skip to content

   Pharma Publications

Neuropsychopharmacology
  • Integration of developmental and socio-cultural factors that confer risk for mental illness
    Published on 2025-07-31
    4 months ago
  • A biological phenotype of suicide attempt in adolescents with nonsuicidal self-injury: a machine-based learning approach
    Published on 2025-07-29
    4 months ago
  • Leveraging single-cell spatial transcriptomics and connectomics to resolve brain circuit function in psychiatry
    Published on 2025-07-28
    4 months ago
  • Field experimentation enhances translation for behavioral neuroscience
    Published on 2025-07-25
    4 months ago
  • Understanding the emergence of suicidal thoughts and behaviors in adolescence from a brain and behavioral developmental perspective
    Published on 2025-07-25
    4 months ago
  • Does cannabidiol reduce the adverse effects of cannabis in schizophrenia? A randomised, double-blind, cross-over trial
    Published on 2025-07-24
    5 months ago
  • Timing matters: modeling the effects of gestational cannabis exposure on social behavior and microglia in the developing amygdala
    Published on 2025-07-23
    5 months ago
« Previous 1 … 14 15 16 17 18 … 143 Next »
Journal of Psychopharmacology
  • Circadian rhythmicity in prepulse inhibition of the acoustic startle response: A study of chronotype and time-of-day effects in young healthy adults
    Published on 2025-05-15
    7 months ago
  • CYP1A2 genotype-dependent effects of smoking on mirtazapine serum concentrations
    Published on 2025-05-12
    7 months ago
  • Set and setting of psychedelics for therapeutic use in psychiatry: A systematic review
    Published on 2025-05-12
    7 months ago
  • The effects of menthol content on the abuse liability of smokeless tobacco in a randomized crossover trial
    Published on 2025-05-08
    7 months ago
  • Brexpiprazole augmentation and mitochondrial gene expression changes in major depressive disorder
    Published on 2025-05-06
    7 months ago
  • Are the LSD-analogs lisuride and ergotamine examples of non-hallucinogenic serotonin 5-HT2A receptor agonists?
    Published on 2025-05-05
    7 months ago
  • Pictorial representation of illness and self measure (PRISM): A putative transdiagnostic tool for evaluating therapeutic effects of psychedelic treatments
    Published on 2025-05-05
    7 months ago
« Previous 1 … 14 15 16 17 18 … 134 Next »
European Neuropsychopharmacology
  • Sex differences in schizophrenia-related mortality: A call for targeted interventions
    Published on 2025-03-07
    9 months ago
  • Commentary on “Sex-stratified mortality estimates in people with schizophrenia: A systematic review and meta-analysis of cohort studies of 2,700,825 people with schizophrenia” by Solmi and colleagues
    Published on 2025-03-07
    9 months ago
  • Chronic mild stress dysregulates autophagy, membrane dynamics, and lysosomal status in frontal cortex and hippocampus of rats
    Published on 2025-03-07
    9 months ago
  • The promise and challenges of mHealth in psychiatry: Bridging the gap between potential and long-awaited implementation
    Published on 2025-03-07
    9 months ago
  • Measuring the clinical dimensions of negative symptoms through the Positive and Negative Syndrome Scale
    Published on 2025-02-27
    9 months ago
  • The role of esketamine in persistent long COVID with predominant psychiatric manifestations
    Published on 2025-02-27
    9 months ago
  • The cumulative production and conjugation of steroid hormones during pregnancy predict postpartum depressive mood
    Published on 2025-02-22
    10 months ago
« Previous 1 … 14 15 16 17 18 … 153 Next »

   Pharma Pub